Wernicke's encephalopathy in a child with Down syndrome, undergoing treatment for acute lymphoblastic leukemia.
Department of Pediatric Hematology, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
Ayşen Türedi
AT
Yıldırım
Department of Pediatrics, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
Gökmen
G
Bilgili
Department of Pediatrics, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
Bilge
B
Akman
Department of Radiology, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
Gülgün Yılmaz
GY
Ovalı
Department of Pediatric Hematology Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
Ali Aykan
AA
Özgüven
Department of Pediatric Hematology Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey.
Hüseyin
H
Gülen
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging; D002648:Child; D004314:Down Syndrome / Q000150:complications*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014899:Wernicke Encephalopathy / Q000150:complications* / Q000175:diagnosis
D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate
Down syndrome; Wernicke's encephalopathy; acute lymphoblastic leukemia